Maximizing insights from monogenic immune disorders.

Monogenic immune disorders provide unprecedented insights into the consequences of disrupting single genes in humans, thereby informing our understanding of fundamental immune function and disease. At this juncture, the optimal path forward will focus on maximizing basic and translational immunology insights from these disorders.

⚡ This is an original paraphrased summary — not copied from the abstract. Full paper available at the source link below.

• 1 Genomics has accelerated monogenic disease discovery while also revealing the complexity of human disease, where several factors beyond the genome can govern pathogenesis.
• 2 At this juncture, the optimal path forward will focus on maximizing basic and translational immunology insights from these disorders.
• 3 This pursuit will be most direct and impactful if human disease gene discovery is paired with mechanistic studies employing integrative omics and mouse modeling to leverage their unique strengths.

Understanding this could lead to better treatments, improved diagnostics, or a deeper grasp of how the human body works — benefiting patient care globally.

This summary is based on publicly available metadata and abstract. For the full research paper, visit the original source: